Maternal serum NRF2 at 12 weeks as a biomarker for development of gestation diabetes mellitus
Decreased maternal serum NFR2 levels at 12 weeks' gestation appear to be associated with an increased risk of developing GDM later in pregnancy. Combining this marker, together with FT4, MAP and potentially FPG may serve as a useful first-trimester screening for the risk to develop GDM.
Authors
- Jing Ge (ORCID: https://orcid.org/0000-0002-2640-8341)
- Xiaozhou Jia (ORCID: https://orcid.org/0000-0002-7966-4728)
- Dan Lu
- Lingling Wang
- Wenjuan Tang
Institutions
- Hunan Provincial Maternal and Child Health Hospital (CN)
Publication Details
- Journal
- Archives of Gynecology and Obstetrics
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1007/s00404-026-08327-0
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00